ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Other/Sorafenib
C21H16ClF3N4O3
464.8 g/mol
OtherDanger

Sorafenib

CAS284461-73-0EC608-209-4
Category
Other
Compound Class
n.a
Primary Use
Multikinase inhibitor for cancer research

Sorafenib is a multikinase inhibitor studied for its role in cancer treatment. It is characterized as an aromatic, heterocyclic compound containing amide, ether, and halogen functional groups.

Antineoplastic agentsProtein kinase inhibitors

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 284461-73-0

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

StrongSame Parent

Sorafenib tosylate

CAS475207-59-1

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.83

Regorafenib

CAS755037-03-7

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.83

Regorafenib monohydrate

CAS1019206-88-2

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.74

4-[4-[[[[2-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide

CAS1431697-81-2

pharmaceutical intermediate

ReferenceSame Category

3-Chloroanisole

CAS2845-89-8

Research intermediate

ReferenceSame Category

Methyl 3,5-dichloro-4-hydroxybenzoate--water (1/1)

CAS287399-19-3

Laboratory reagent

ReferenceSame Category

Heptylboronic acid

CAS28741-07-3

Laboratory reagent for research

ReferenceSame Category

1-(2-(Ethylthio)ethyl)-2-methyl-5-nitro-1H-imidazole

CAS28795-33-7

Pharmaceutical intermediate or research compound

Safety Reference

Harmful
Harmful
Health Hazard
Health Hazard
Environmental Hazard
Environmental Hazard
Danger
H351Suspected of causing cancer
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
H362May cause harm to breast-fed children
H372Causes damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H402Harmful to aquatic life
H410Very toxic to aquatic life with long lasting effects
Identifiers
IUPAC Name

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide

InChIKey

MLDQJTXFUGDVEO-UHFFFAOYSA-N

SMILES

CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F

Synonyms (38)
  • BAX
  • Sorafenib (USAN/INN)
  • 1uwh
  • 284461-73-0 (free base)
  • 3gcs
  • 3heg
  • 4asd
  • BA4 43 9006
  • BAY 43-9006
  • BAY 43-9006; Sorafenib
  • BAY 545 9085
  • Hit compound, 8
  • K00597a
  • Nexavar (TN) (Bayer)
  • SORAFENIB [MART.]
  • Sorafenib
  • Sorafenib (Base)
  • Sorafenib (Nexavar)
  • Sorafenib (Standard)
  • Sorafenib - Bio-X trade mark
  • Sorafenib free base
  • Sorafenib, 4
  • sorafenib tosilate hydrate
  • sorafenibum